Masato Okamoto

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer.

Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer.

Journal: Cancer investigation
Published: September 07, 2019

Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1.

Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1.

Journal: Oncology
Published: March 30, 2019

Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines.

Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines.

Journal: Human vaccines & immunotherapeutics
Published: September 20, 2018

Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors.

Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors.

Journal: Anticancer research
Published: February 10, 2018

WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study.

WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study.

Journal: Anticancer research
Published: January 16, 2018

Significance of Wilms' tumor 1 antigen as a cancer vaccine for pancreatic cancer.

Significance of Wilms' tumor 1 antigen as a cancer vaccine for pancreatic cancer.

Journal: Discovery medicine
Published: September 27, 2017

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma.

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma.

Journal: Melanoma research
Published: March 07, 2017

Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.

Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.

Journal: Oncology letters
Published: February 26, 2017

Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer.

Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer.

Journal: Oncology letters
Published: January 31, 2017

Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer.

Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer.

Journal: Immunotherapy
Published: December 21, 2016

Dendritic cell-based cancer immunotherapy for colorectal cancer.

Dendritic cell-based cancer immunotherapy for colorectal cancer.

Journal: World journal of gastroenterology
Published: February 11, 2016

Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer.

Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer.

Journal: World journal of gastroenterology
Published: January 14, 2016
Showing 1-12 of 51

Last Updated: 09/26/2026